Literature DB >> 10655197

Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome.

T Abe1, M Sato, M Tamai.   

Abstract

BACKGROUND/AIMS: Varicella zoster virus (VZV) is a causative agent in acute retinal necrosis (ARN) syndrome. However, in spite of aggressive antiviral therapy, clinical characteristics among patients have varied. Different viral strains were examined to determine their respective role in producing clinical characteristics. The viral strains were also compared with those of previously reported ones.
METHODS: To differentiate VZV strains R1 and R5, variable regions of VZV were amplified by nested polymerase chain reaction (PCR) in 11 eyes of 10 patients. Sequence analysis was also performed.
RESULTS: Four cases had strains diverted only at the tip of the 3' end of the R1 variable region, similar to that of the H-N3 strain, which was previously reported. Conversely, other cases were diverted to other regions. Interestingly, some of the latter cases showed multiple PCR products in the R1 region that were generated by the truncation of either the 5' or 3' R1 region. Final visual acuities of these patients were less than 0.2. The former cases showed final visual acuities more than 0.4. Only two variants were from the R5 region. No patient had the same viral strain as the European Dumas type.
CONCLUSION: These results showed that variable VZV strains participated in ARN. Using PCR of the R1 variable region, it was estimated that patients with a more fulminant type of ARN may have diverse viruses with extensive replication in the affected eyes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655197      PMCID: PMC1723368          DOI: 10.1136/bjo.84.2.193

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA.

Authors:  T G Buchman; B Roizman; A J Nahmias
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

2.  Development of a live attenuated varicella vaccine.

Authors:  M Takahashi; Y Okuno; T Otsuka; J Osame; A Takamizawa
Journal:  Biken J       Date:  1975-03

3.  Recurrent nodular scleritis associated with varicella zoster virus.

Authors:  C Livir-Rallatos; Y El-Shabrawi; P Zatirakis; P E Pellett; F R Stamey; C S Foster
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

4.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

5.  Typing of varicella zoster virus by amplification of DNA polymorphisms.

Authors:  K Hawrami; D Harper; J Breuer
Journal:  J Virol Methods       Date:  1996-04-05       Impact factor: 2.014

6.  Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak.

Authors:  T G Buchman; B Roizman; G Adams; B H Stover
Journal:  J Infect Dis       Date:  1978-10       Impact factor: 5.226

7.  Immunological profiles in patients with acute retinal necrosis.

Authors:  C Rochat; B S Polla; C P Herbort
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

8.  Investigation of vesicular rashes for HSV and VZV by PCR.

Authors:  G Beards; C Graham; D Pillay
Journal:  J Med Virol       Date:  1998-03       Impact factor: 2.327

9.  Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region.

Authors:  M Takada; T Suzutani; I Yoshida; M Matoba; M Azuma
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Correlation of varicella-zoster virus copies and final visual acuities of acute retinal necrosis syndrome.

Authors:  T Abe; M Sato; M Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-10       Impact factor: 3.117

View more
  5 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 2.  [Diagnostic vitrectomy in uveitis: possibilities of molecular biology].

Authors:  M D Becker; B Bodaghi; F G Holz; N Harsch; P Le Hoang
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

Review 3.  [Molecular biology-based methods for pathogen detection in endophthalmitis].

Authors:  S Zimmermann; A Dalpke
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

4.  Interferon gamma expression and clinical features in patients with acute retinal necrosis syndrome.

Authors:  Toshiaki Abe; Masami Sato; Yoko Saigo; Makoto Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-20       Impact factor: 3.117

5.  Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus.

Authors:  Nancy J Jensen; Daniel P Depledge; Terry Fei Fan Ng; Jessica Leung; Mark Quinlivan; Kay W Radford; Jennifer Folster; Hung-Fu Tseng; Philip LaRussa; Steven J Jacobsen; Judith Breuer; D Scott Schmid
Journal:  Virology       Date:  2020-04-04       Impact factor: 3.513

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.